• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外神经炎症模型:大麻萜酚,一种非精神活性大麻素的疗效。

In Vitro Model of Neuroinflammation: Efficacy of Cannabigerol, a Non-Psychoactive Cannabinoid.

机构信息

IRCCS Centro Neurolesi "Bonino Pulejo", 98124 Messina, Italy.

Department of Pharmaceutical Sciences, University of Eastern Piedmont "Amedeo Avogadro", 28100 Novara, Italy.

出版信息

Int J Mol Sci. 2018 Jul 8;19(7):1992. doi: 10.3390/ijms19071992.

DOI:10.3390/ijms19071992
PMID:29986533
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6073490/
Abstract

Inflammation and oxidative stress play main roles in neurodegeneration. Interestingly, different natural compounds may be able to exert neuroprotective actions against inflammation and oxidative stress, protecting from neuronal cell loss. Among these natural sources, represents a reservoir of compounds exerting beneficial properties, including cannabigerol (CBG), whose antioxidant properties have already been demonstrated in macrophages. Here, we aimed to evaluate the ability of CBG to protect NSC-34 motor neurons against the toxicity induced from the medium of LPS-stimulated RAW 264.7 macrophages. Using MTT assay, we observed that CBG pre-treatment was able to reduce the loss of cell viability induced by the medium of LPS-stimulated macrophages in NSC-34 cells. Indeed, CBG pre-treatment inhibited apoptosis, as shown by the reduction of caspase 3 activation and Bax expression, while Bcl-2 levels increased. Furthermore, CBG pre-treatment counteracted not only inflammation, as demonstrated by the reduction of IL-1β, TNF-α, IFN-γ and PPARγ protein levels assessed by immunocytochemistry, but also oxidative stress in NSC-34 cells treated with the medium of LPS-stimulated RAW 264.7. Indeed, immunocytochemistry showed that CBG pre-treatment reduced nitrotyrosine, SOD1 and iNOS protein levels and restored Nrf-2 levels. All together, these results indicated the neuroprotective effects of CBG, that may be a potential treatment against neuroinflammation and oxidative stress.

摘要

炎症和氧化应激在神经退行性变中起主要作用。有趣的是,不同的天然化合物可能能够发挥神经保护作用,对抗炎症和氧化应激,从而防止神经元细胞丢失。在这些天然来源中,大麻代表了发挥有益特性的化合物的宝库,包括大麻素二醇(CBG),其抗氧化特性已在巨噬细胞中得到证实。在这里,我们旨在评估 CBG 保护 NSC-34 运动神经元免受 LPS 刺激的 RAW 264.7 巨噬细胞培养基毒性的能力。通过 MTT 测定,我们观察到 CBG 预处理能够减少 LPS 刺激的巨噬细胞培养基诱导的 NSC-34 细胞活力丧失。事实上,CBG 预处理抑制了细胞凋亡,这表现为 caspase 3 激活和 Bax 表达减少,而 Bcl-2 水平增加。此外,CBG 预处理不仅对抗了炎症,如通过免疫细胞化学评估的 IL-1β、TNF-α、IFN-γ和 PPARγ蛋白水平的降低所示,而且还对抗了 LPS 刺激的 RAW 264.7 巨噬细胞培养基处理的 NSC-34 细胞中的氧化应激。事实上,免疫细胞化学显示 CBG 预处理降低了硝基酪氨酸、SOD1 和 iNOS 蛋白水平,并恢复了 Nrf-2 水平。所有这些结果表明了 CBG 的神经保护作用,它可能是一种针对神经炎症和氧化应激的潜在治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/514c/6073490/7606f0efb3e9/ijms-19-01992-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/514c/6073490/c974881870c0/ijms-19-01992-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/514c/6073490/8a028dfd0215/ijms-19-01992-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/514c/6073490/77957322808b/ijms-19-01992-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/514c/6073490/69aa5e9666ce/ijms-19-01992-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/514c/6073490/234ee45bb963/ijms-19-01992-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/514c/6073490/7606f0efb3e9/ijms-19-01992-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/514c/6073490/c974881870c0/ijms-19-01992-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/514c/6073490/8a028dfd0215/ijms-19-01992-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/514c/6073490/77957322808b/ijms-19-01992-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/514c/6073490/69aa5e9666ce/ijms-19-01992-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/514c/6073490/234ee45bb963/ijms-19-01992-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/514c/6073490/7606f0efb3e9/ijms-19-01992-g006.jpg

相似文献

1
In Vitro Model of Neuroinflammation: Efficacy of Cannabigerol, a Non-Psychoactive Cannabinoid.体外神经炎症模型:大麻萜酚,一种非精神活性大麻素的疗效。
Int J Mol Sci. 2018 Jul 8;19(7):1992. doi: 10.3390/ijms19071992.
2
Cannabinoid CB2 receptors are involved in the protection of RAW264.7 macrophages against the oxidative stress: an in vitro study.大麻素CB2受体参与RAW264.7巨噬细胞抗氧化应激保护作用的体外研究。
Eur J Histochem. 2017 Jan 23;61(1):2749. doi: 10.4081/ejh.2017.2749.
3
Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: possible involvement of different binding sites at the PPARγ receptor.大麻萜酚醌衍生物 VCE-003.2 对抗实验性帕金森病中炎症驱动的神经元恶化的益处:可能涉及 PPARγ 受体的不同结合位点。
J Neuroinflammation. 2018 Jan 16;15(1):19. doi: 10.1186/s12974-018-1060-5.
4
Conditioned medium from human gingival mesenchymal stem cells protects motor-neuron-like NSC-34 cells against scratch-injury-induced cell death.人牙龈间充质干细胞条件培养基可保护运动神经元样 NSC-34 细胞免受划痕损伤诱导的细胞死亡。
Int J Immunopathol Pharmacol. 2017 Dec;30(4):383-394. doi: 10.1177/0394632017740976. Epub 2017 Nov 15.
5
Could the Combination of Two Non-Psychotropic Cannabinoids Counteract Neuroinflammation? Effectiveness of Cannabidiol Associated with Cannabigerol.两种非精神性大麻素的联合应用能否对抗神经炎症?大麻二酚与大麻萜酚联合应用的效果。
Medicina (Kaunas). 2019 Nov 18;55(11):747. doi: 10.3390/medicina55110747.
6
Cannabidiol and Cannabigerol Inhibit Cholangiocarcinoma Growth In Vitro via Divergent Cell Death Pathways.大麻二酚和大麻萜酚通过不同的细胞死亡途径抑制胆管癌细胞系的体外生长。
Biomolecules. 2022 Jun 20;12(6):854. doi: 10.3390/biom12060854.
7
Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib against toxicity of LPS-stimulated macrophages toward motor neurons.环氧化酶-2抑制剂塞来昔布对脂多糖刺激的巨噬细胞毒性作用的神经保护作用对运动神经元的影响。 (这段译文表述稍显生硬,可优化为:环氧化酶-2抑制剂塞来昔布对脂多糖刺激的巨噬细胞毒害运动神经元的作用具有神经保护效应 )
Acta Pharmacol Sin. 2005 Aug;26(8):952-8. doi: 10.1111/j.1745-7254.2005.00136.x.
8
In Vitro and Clinical Evaluation of Cannabigerol (CBG) Produced via Yeast Biosynthesis: A Cannabinoid with a Broad Range of Anti-Inflammatory and Skin Health-Boosting Properties.酵母生物合成大麻萜酚(CBG)的体外和临床评价:具有广泛抗炎和皮肤健康促进特性的大麻素。
Molecules. 2022 Jan 13;27(2):491. doi: 10.3390/molecules27020491.
9
Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease.大麻素大麻萜二醇对实验性炎症性肠病的有益作用。
Biochem Pharmacol. 2013 May 1;85(9):1306-16. doi: 10.1016/j.bcp.2013.01.017. Epub 2013 Feb 12.
10
Antioxidant and Neuroprotective Effects Induced by Cannabidiol and Cannabigerol in Rat CTX-TNA2 Astrocytes and Isolated Cortexes.大麻二酚和大麻萜酚对 CTX-TNA2 星形胶质细胞和离体皮质诱导的抗氧化和神经保护作用。
Int J Mol Sci. 2020 May 18;21(10):3575. doi: 10.3390/ijms21103575.

引用本文的文献

1
Cannabigerol Attenuates Memory Impairments, Neurodegeneration, and Neuroinflammation Caused by Transient Global Cerebral Ischemia in Mice.大麻二酚可减轻小鼠短暂性全脑缺血引起的记忆障碍、神经退行性变和神经炎症。
Int J Mol Sci. 2025 Aug 20;26(16):8056. doi: 10.3390/ijms26168056.
2
Exploring the impact of chronic intermittent EU-GMP certified Cannabis sativa L. therapy and its relevance in a rat model of aging.探索慢性间歇性欧盟药品生产质量管理规范(EU-GMP)认证的大麻治疗的影响及其在大鼠衰老模型中的相关性。
J Cannabis Res. 2025 Aug 6;7(1):53. doi: 10.1186/s42238-025-00313-8.
3
Hepatotoxicity evaluation of cannabidiol, cannabinol, cannabichromene and cannabigerol using a human quad culture liver chip.

本文引用的文献

1
The Role of Macrophages in Neuroinflammatory and Neurodegenerative Pathways of Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis: Pathogenetic Cellular Effectors and Potential Therapeutic Targets.巨噬细胞在阿尔茨海默病、肌萎缩侧索硬化症和多发性硬化症的神经炎症和神经退行性途径中的作用:发病机制的细胞效应物和潜在治疗靶点。
Int J Mol Sci. 2018 Mar 13;19(3):831. doi: 10.3390/ijms19030831.
2
Eruca sativa seed extract: A novel natural product able to counteract neuroinflammation.芝麻菜籽油提取物:一种新型天然产物,可对抗神经炎症。
Mol Med Rep. 2018 May;17(5):6235-6244. doi: 10.3892/mmr.2018.8695. Epub 2018 Mar 7.
3
使用人源四细胞共培养肝脏芯片对大麻二酚、大麻酚、大麻色烯和大麻萜酚进行肝毒性评估。
Sci Rep. 2025 Aug 1;15(1):28132. doi: 10.1038/s41598-025-12846-2.
4
Cannabigerol Alleviates Liver Damage in Metabolic Dysfunction-Associated Steatohepatitis Female Mice via Inhibition of Transforming Growth Factor Beta 1.大麻二酚通过抑制转化生长因子β1减轻代谢功能障碍相关脂肪性肝炎雌性小鼠的肝损伤。
Nutrients. 2025 Apr 30;17(9):1524. doi: 10.3390/nu17091524.
5
Comprehensive mini-review: therapeutic potential of cannabigerol - focus on the cardiovascular system.综述:大麻二酚的治疗潜力——聚焦于心血管系统
Front Pharmacol. 2025 Mar 26;16:1561385. doi: 10.3389/fphar.2025.1561385. eCollection 2025.
6
A systematic study of molecular targets of cannabidiol in Alzheimer's disease.大麻二酚在阿尔茨海默病中分子靶点的系统研究。
J Alzheimers Dis Rep. 2024 Oct 11;8(1):1339-1360. doi: 10.1177/25424823241284464. eCollection 2024.
7
Cannabigerol Treatment Shows Antiproliferative Activity and Causes Apoptosis of Human Colorectal Cancer Cells.大麻二酚治疗显示出抗增殖活性并导致人结肠癌细胞凋亡。
J Pharmacopuncture. 2024 Dec 31;27(4):332-339. doi: 10.3831/KPI.2024.27.4.332.
8
CD47 signaling induces hepatic cell death and microglia activation during hepatic encephalopathy.CD47信号传导在肝性脑病期间诱导肝细胞死亡和小胶质细胞激活。
Metab Brain Dis. 2024 Dec 10;40(1):57. doi: 10.1007/s11011-024-01493-7.
9
Cannabigerol (CBG): A Comprehensive Review of Its Molecular Mechanisms and Therapeutic Potential.大麻萜酚(CBG):其分子机制和治疗潜力的全面综述。
Molecules. 2024 Nov 20;29(22):5471. doi: 10.3390/molecules29225471.
10
Investigation in the cannabigerol derivative VCE-003.2 as a disease-modifying agent in a mouse model of experimental synucleinopathy.大麻二酚衍生物 VCE-003.2 作为一种实验性突触核蛋白病模型中的疾病修饰剂的研究。
Behav Brain Funct. 2024 Nov 1;20(1):28. doi: 10.1186/s12993-024-00256-9.
13 reasons why the brain is susceptible to oxidative stress.
大脑易受氧化应激影响的 13 个原因。
Redox Biol. 2018 May;15:490-503. doi: 10.1016/j.redox.2018.01.008. Epub 2018 Feb 3.
4
Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: possible involvement of different binding sites at the PPARγ receptor.大麻萜酚醌衍生物 VCE-003.2 对抗实验性帕金森病中炎症驱动的神经元恶化的益处:可能涉及 PPARγ 受体的不同结合位点。
J Neuroinflammation. 2018 Jan 16;15(1):19. doi: 10.1186/s12974-018-1060-5.
5
The role of Nrf2 signaling in counteracting neurodegenerative diseases.Nrf2 信号通路在对抗神经退行性疾病中的作用。
FEBS J. 2018 Oct;285(19):3576-3590. doi: 10.1111/febs.14379. Epub 2018 Jan 29.
6
Role of mitochondrial ROS in the brain: from physiology to neurodegeneration.线粒体 ROS 在大脑中的作用:从生理学到神经退行性变。
FEBS Lett. 2018 Mar;592(5):692-702. doi: 10.1002/1873-3468.12964. Epub 2018 Jan 18.
7
Roles of Peroxisome Proliferator-Activated Receptor Gamma on Brain and Peripheral Inflammation.过氧化物酶体增殖物激活受体 γ 在脑和外周炎症中的作用。
Cell Mol Neurobiol. 2018 Jan;38(1):121-132. doi: 10.1007/s10571-017-0554-5. Epub 2017 Oct 3.
8
CNS inflammation and neurodegeneration.中枢神经系统炎症与神经退行性变。
J Clin Invest. 2017 Oct 2;127(10):3577-3587. doi: 10.1172/JCI90609. Epub 2017 Sep 5.
9
Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications.神经退行性疾病中的氧化应激:从分子机制到临床应用
Oxid Med Cell Longev. 2017;2017:2525967. doi: 10.1155/2017/2525967. Epub 2017 Jul 12.
10
KEAP1-modifying small molecule reveals muted NRF2 signaling responses in neural stem cells from Huntington's disease patients.KEAP1 修饰小分子揭示亨廷顿病患者神经干细胞中 NRF2 信号反应迟钝。
Proc Natl Acad Sci U S A. 2017 Jun 6;114(23):E4676-E4685. doi: 10.1073/pnas.1614943114. Epub 2017 May 22.